Early Detection Saves Lives: Taking European Cooperation on Cancer Screening to the Next Level

Dolors Montserrat is a Member, EU Special Committee on Beating Cancer and Co-Chair, ENVI... Dolors Montserrat is a Member, EU Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group and Former Spanish Health Minister Member of the European Parliament since July 2019 Head of the EPP Spanish Delegation Chair of the Committee on Petitions Member of the Committee on Environment, Public Health and Food Safety (ENVI) Co-Chair of the Health Working Group at the ENVI Committee Minister of Health, Social Services and Equality from 2016 to 2018 Third Vice President of the Bureau of the Congress of Deputies in the X Legislature Deputy for Barcelona in the Congress of the IX, X, XI and XII legislatures Councillor and spokesperson of the PP Group in the City Hall of Sant Sadurní d’Anoia from 2003 to 2015 Practicing Lawyer from 1997 to 2011, specialized in civil, property and family law She attended the C.O.U in the United States (Memphis, Tennessee) Postgraduate in Urban and Real Estate Law taught by Pompeu Fabra University Postgraduate in Family Mediation and contractual negotiation taught by the University of Barcelona Real estate and urban law program taught by ESADE Real Estate Business Management Program taught by IESE Master of the Legal Practice School of the Barcelona Bar Association Community Agricultural Law Program taught by the University degli Studi di Ferrara (Italy) She completed the last year of Law Degree at the University of Studies of Ferrara (Italy) with the ERASMUS program Law degree from the Abad Oliba CEU (Barcelona) She studied basic knowledge of German at Freiburg University (Germany) She has been President of the Young Confraria del Cava of Sant Sadurní d 'Anoia Read more Show less

Henricus J. de Koning is Deputy Head, Public Health and Screening Evaluation, Department of... Henricus J. de Koning is Deputy Head, Public Health and Screening Evaluation, Department of Public Health, Erasmus MC. Work Experience and Appointments Since Graduation 1986 – 1987 Teaching Anatomy and Pathology to nurses 1987 – 1995 Researcher, Department of Public Health, Erasmus University Rotterdam. 1995 – 1999 Assistant professor, Department of Public Health, Erasmus University Rotterdam. 1999 – 2008 Associate professor, Department of Public Health, Erasmus University Rotterdam. 2008 – present Professor of Public Health & Screening Evaluation, Department of Public Health, Erasmus MC. Inaugural address: De mysterieuze massa; The mysterious mass(es). 26th June 2009. 2011 – 2012 Senior Associate Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health. 2011 – 2017 Member Medical Advisory Board of the Royal Netherlands Academy of Arts and Sciences (KNAW). Read more Show less

Isabel T. Rubio is the Co-Chair of the European Cancer Summit 2020, Board Member of the European... Isabel T. Rubio is the Co-Chair of the European Cancer Summit 2020, Board Member of the European Cancer Organisation, Prevention Network Co-Chair, Head of Breast Surgical Oncology at Clinica Universidad de Navarra in Madrid, Spain and Professor of Surgery at the Universidad de Navarra, Spain. She completed her Medical degree at the Faculty of Medicine in Salamanca, Spain, and become a Board-certified General Surgeon. She had additional training for two years as a Breast Surgical Oncology Fellow at The University of Arkansas for Medical Sciences and the Arkansas Cancer Center at Little Rock, USA and for one year at the MD Anderson Cancer Center in Houston, Texas, USA. She completed her PhD in 2000. She is the director of the Breast Surgery Fellowship program at her Institution. Dr. Rubio is active in many societies, founding member and past President of the Spanish Association of Breast Surgeons (AECIMA), EUSOMA President-Elect (European Society of Breast Cancer Specialists), Chief, Public Affairs of the European Society of Surgical Oncology (ESSO), member of the American Society of Breast Surgeons and member of the Outreach Committee of the Society of Surgical Oncology (SSO). She is the breast section editor of the Journal of Surgical Oncology, reviewer for The Breast, the European Journal of Surgical Oncology and Annals of Surgical Oncology. She obtained the European Board of Surgery Qualification in Breast Surgery and since 2015 is officer at the UEMS Breast Surgery Division and participates as an examiner in the EBSQ Examinations in Breast Surgery. Dr. Rubio is involved as part of the Steering and Executive Committees in several international, multicenter randomized trials. She has received grants to develop her research by the Susan G. Komen Foundation, Spanish Ministry of Health and other institutions. Dr. Rubio has published over 100 national and international peer review manuscripts and book chapters. She has presented her work in many of the main international meetings in breast cancer. Her interest is in sentinel lymph node biopsy, neoadjuvant treatments, surgical management of BRCA mutation carriers and the role of prognostic markers (genomic profiles, liquid biopsy). Also her interest is focused on the standardization of Breast cancer surgical training and Breast units. Read more Show less

Jan van Meerbeeck is Board Member, European Cancer Organisation and Prevention Network Co-Chair.... Jan van Meerbeeck is Board Member, European Cancer Organisation and Prevention Network Co-Chair. After obtaining his medical degree magna cum laude from the University of Antwerp in 1980, Prof van Meerbeeck completed training to become a board certified specialist in internal medicine and pulmonology. He is a skilled interventional pulmonologist and obtained his PhD in 1997 with a dissertation on the presentation of lung cancer in Flanders, Belgium. He is currently professor of Thoracic Oncology at both Ghent and Antwerp University and practiced as pulmonologist at Antwerp University Hospital, Belgium and at Erasmus MC, the Netherlands. He was Chair of the Thoracic Oncology Program at Ghent University Hospital, where he became also Divisional Head and CMO. He is currently appointed full professor in Pulmonology @ Antwerp University and chair of the Pulmonology Department of its academic hospital (UZA). His translational scientific interests include the molecular diagnosis of lung cancer, the management of mesothelioma and the evaluation of volatile biomarkers of asbestos exposure. He is or was the study coordinator or Principal Investigator for numerous international phase 2 and 3 studies in thoracic oncology and respiratory medicine and promoter of several master thesis and PhD students, of which 7 successfully obtained their PhD. Together with Kevin Lamote, he is the founder of the breathomics lab within the Laboratory of experimental medicine and pediatrics (LEMP) @ University of Antwerp. He is furthermore fellow of the European Respiratory Society (ERS) and serves its Thoracic Oncology Assembly as current chair and member of the mesothelioma guideline committee. He served the Lung Cancer Group of the EORTC as secretary, chairman and as board member, is a full member of the ASCO and the IASLC (current member of its staging committee), and expert at the Belgian HTA Knowledge Center KCE. He was involved in the development of the ICHOM standard set on Lung cancer and board member of All.Can and All.Can Belgium. He has an extensive presentation and publication track, with more than 300 peer-reviewed articles in various journals and chapters in textbooks. He serves on the review and editorial boards of several international journals, and organized several national and international meetings. Read more Show less

Padraic Ward is Head of Commercial Operations, Roche. He joined the company in 2004 and has... Padraic Ward is Head of Commercial Operations, Roche. He joined the company in 2004 and has worked in a number of key roles including leading the team bringing a new medicine for breast cancer through the final stages of development and regulatory approval, and leading the commercial organisation first in France and then in Europe. He was appointed to his current role as Head of Commercial Operations for Roche Pharma International in June 2018. Before joining Roche, Padraic worked for Coras Tráchtála (CTT)/Irish Export Board, as a strategic consultant in the industrial and distribution sector, and for Glaxo, first on the launch of new medicines for infectious diseases, particularly HIV and viral hepatitis, then as Commercial Strategy Director in Glaxo Wellcome’s Latin America Regional Office in Rio de Janeiro, Brazil. Padraic holds a Bachelor of Commerce degree from the University College Dublin and an MBA from INSEAD. Read more Show less

Dr Partha Basu is Head, Screening Group, Early Detection and Prevention Section, International... Dr Partha Basu is Head, Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, World Health Organization. He was Head of Gynecological Oncology at Chittaranjan National Cancer Institute, India before joining IARC in 2015. Dr Basu’s current research projects include: a) cohort study to evaluate single dose of HPV vaccine; b) RCT to evaluate a new Indian HPV vaccine; c) evaluation of thermal ablation; d) evaluation of artificial intelligence based device for cervical cancer early detection; e) study of vaginal microbiome in HIV+ women; f) RCT to evaluate CBE; g) evaluation of automated breast ultrasound; h) evaluation of cancer screening programmes in Europe and Latin America; i) evaluation of colorectal cancer screening in Mediterranean Region. These projects are funded by National Institute of Health (USA), Gates Foundation, American Cancer Society, Norwegian Research Council, Swiss Cancer Research, Lalla Salma Foundation (Morocco), Indo-American Cancer Association etc. Read more Show less

Stefan Gijssels is Chief Executive Officer and Member of the Board of Digestive Cancers Europe,... Stefan Gijssels is Chief Executive Officer and Member of the Board of Digestive Cancers Europe, the umbrella organisation of all digestive cancer patient associations in Europe (oesophageal, gastric, pancreatic, colon, rectum, liver and rare digestive cancers). The organisation represents more than 30 national associations. In this capacity, he is also member of the European Commission’s Innovative Partnership for Action Against Cancer (iPAAC), and of the European Reference Network of Rare Cancers (EURACAN). He is one of the founders and Board Member of the Patient Expert Center in Belgium. He is Co-Chair of the Patient Advisory Committee of the European Cancer Organisation, and a member of its Executive Committee. Stefan is a metastatic colon cancer survivor. Since 2016, he also works as an independent health policy advisor, publicist, facilitator and moderator, working for public health authorities, patient organisations and industry. Until 2016, he was Vice President Communication & Public Affairs at Janssen Europe, Middle East & Africa. In the 90s he was director and general manager at Burson-Marsteller, Vice-President at Weber-Shandwick, Public Affairs Manager at McDonald’s, and Project Manager at the Institute of the Enterprise, a Belgian policy think tank. He started his career as an English teacher in Morocco. He has a a master’s degree in Literature and Philosophy from Leuven University, Belgium. Read more Show less

Professor Albreht is a Senior Health Services and Health Systems Researcher at the National... Professor Albreht is a Senior Health Services and Health Systems Researcher at the National Institute of Public Health of Slovenia. He specializes in social medicine and, having completed his doctorate at the University of Amsterdam, he dedicates his research to the exploration of health services – nationally and internationally. He is particularly interested in the performance of health systems, evidence-based health policy, health workforce planning and mobility, and development of more efficient health care, especially in the field of noncommunicable diseases. Professor Albreht is an associate professor of public health at the Faculty of Medicine, University of Ljubljana, and a member of the Scientific Committee of the European Public Health Association. He acts as a reviewer for several international and national medical and public health journals. Since 2006, he has been actively involved in the development of cancer policies at the European level – during the Slovenian Presidency of the European Council and later as coordinator of Joint Actions on cancer policy at the European Union level, including the European Partnership for Action Against Cancer (EPAAC), Cancer Control (CanCon) and most recently, the Innovative Partnership for Action Against Cancer (iPAAC). Professor Albreht has worked in a number of projects for policy support in various countries of south-eastern Europe (Bosnia and Herzegovina, Macedonia, the Republic of Moldova, Montenegro and Serbia) and also in Kazakhstan. These consultancies have included: support for the development of public health legislation, cancer control and public health interventions. All of these projects were in support of the policies of the respective ministries of health. Read more Show less